Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Shire, Mothercare, Blinkx, Barclays

Sun, 06th Jul 2014 17:18

AbbVie is expected to make an improved offer for Shire in the next few days after its Chief Executive Rick Gonzalez visited Shire's biggest investors in London, The Sunday Times said. Gonzalez is back in the US mulling his options after having three bid approaches turned down with the most recent valuing Shire at £27bn. Some observers say the US company will have to offer at least £50 a share to get Shire talking, improving on the £46.11 approach it made at the end of May.AbbVie's Gonzalez told investors on his trip to London that he needed more detail on Shire's target to double revenues by 2020 before considering a higher offer, according to The Sunday Telegraph. But Shire is reluctant to hand over more information in case it sets a precedent for other potential suitors. Richard Marwood, a fund manager at Axa, said an improved bid approach was "still possible".Large shareholders in Mothercare have backed the chain's rejection of a £270m takeover approach from Destination Maternity of the US, The Sunday Telegraph reported. Fidelity and Allianz own more than a fifth of Mothercare's shares and have dismissed Destination's approaches as "opportunistic" and "inadequate". "We would prefer the business to continue... on a standalone basis," Paras Anand, Head of Equities at Fidelity, told the paper. Simon Gergel at Allianz said he was not interested in the bid and that it was "well below the true value of the company".BlackRock has banned its London office from lending out its shares after a short-selling attack on Blinkx, an online advertising company in which BlackRock is the biggest shareholder, The Sunday Telegraph said. In January, Blinkx lost a third of its value in one day when a Harvard Business School professor posted a blog expressing "grave doubts" about its business. Blinkx denied his allegations and the professor was accused of acting as part of a "bear raid" in which short sellers try to force shares lower. At the time, BlackRock was letting its back office lend some of Blinkx stock to short sellers but it has changed its policy.Sir Mike Rake has withdrawn from the running to be Chairman of Barclays, The Sunday Times said. Rake, who is the bank's Deputy Chairman, is also Chairman of BT and has told Barclays the job would not leave him time for his other jobs. Barclays is looking for a replacement for Sir David Walker who took over almost two years ago and said he would serve for three years. Some institutional investors want an external appointment as the next chairman.Britain's big energy companies are heading for a confrontation with Ofgem, their regulator, over a gap of hundreds of millions of pounds between conflicting estimates of amounts to be refunded to customers, The Mail on Sunday said. Ofgem has said the firms, including Centrica and SSE, hold at least £202m belonging to households in dormant accounts and £204m from business customers bit industry sources claim the real figure is less than £250m.Burberry faces an investor revolt over the £20m retention deal handed to Christopher Bailey, its creative director who became Chief Executive in May, The Sunday Times reported. The Investment Management Association has given an "amber top" rating to Burberry's pay policies before the company's annual meeting on July 11th. Under contracts agreed before Bailey replaced Angela Ahrendts at Burberry, Bailey will get 1.35m shares within four years no matter how the company performs.The whistleblower on the bribery scandal at GlaxoSmithKline was at first told to contact a local compliance officer in China, The Sunday Times said. PwC, Glaxo's auditor, initially said the 11 pages of allegations were "likely just spam or phishing", an email that circulated at the accountant's London office said. Glaxo's handling of the matter is being examined as the Serious Fraud Office and regulators scrutinise governance at the UK's biggest drug company. Glaxo said it was following a standard procedure when it referred the whistleblower to the local officer in China.The Financial Conduct Authority is considering investigating advisers on flotations because of complaints they are bending the rules, according to The Sunday Times. Big investment banks have contacted the FCA about the advisers, which help companies choose banks to handle floats. The complaints focus on interviews of research analysts in which it is alleged the advisers try to shape the analysts' views. Interviewing analysts is not against the rules. Banks whose analysts have positive views on the float company are often those chosen as well. The three main float advisers are STJ Advisors, Lazard and Rothschild.Amaya Gaming is considering plans for a multibillion-pound London listing after agreeing to buy PokerStars for $4.9bn, The Sunday Times said. The Canadian online gambling company trades on the Toronto stock exchange and is deciding whether to have a secondary listing in New York or London. Chief Executive David Baazov said no decision between the two cities had been made.The head of the British Bankers' Association has said the era of the traditional high street branch is over. Writing in The Sunday Telegraph, Anthony Browne said hankering after a return to branch-based banking was "out of kilter with what millions of customers want" as digital banking takes off. Branch numbers will continue to fall as in-branch transactions fall 10% each year, though they are unlikely to disappear altogether because some customers do not like technology, Browne said.The Chief Executive of Michelmersh, Britain's biggest brickmaker, has warned that brick stocks are at their lowest in living memory. Martin Warner told The Sunday Telegraph: "Every brick we can make is being sold straight away. I am seeing the lowest brick stocks in living memory across the UK." He added that brick prices were starting to rise after five years of stagnation. The shortage could constrain housebuilding or increase housebuilders' costs.Unrest over pay at FirstGroup is increasing as three investor advisory groups highlight concerns over Chief Executive Tim O'Toole's remuneration for last year, The Sunday Telegraph said. IVIS, which used to be run by the Association of British Insurers, has given the transport group an "amber top" warning while Pirc has advised shareholders to vote against the pay policy at FirstGroup's annual meeting on July 16th. ISS, the US governance consultancy, has recommended voting in favour but has said it is "not without concern".Laura Wade-Gery's promotion to head all of Marks & Spencer's UK stores as well as its online operation has started speculation that she is being lined up to replace Chief Executive Marc Bolland at the helm of the retailer, the Financial Times said. Some were surprised at the kick-boxing enthusiast's promotion because M&S had recently had trouble at its new website, which she oversaw. She will also be up against rivals for the top job when succession comes around.Sean Farrell
More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.